Cytokeratin 19 anticorps (C-Term)
Aperçu rapide pour Cytokeratin 19 anticorps (C-Term) (ABIN2234021)
Antigène
Voir toutes Cytokeratin 19 (KRT19) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CK-19/KRT19 (Cytokeratin-19)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the C-terminal of human CK19.
-
Isotype
- IgG
-
-
anti-Keratin 19 (KRT19) antibody
KRT19 Reactivité: Humain WB, ELISA, IHC (p), ICC, IP, ICFC Hôte: Souris Monoclonal A53-B-A2 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reactivité: Humain WB, IHC (p), ICC, IP, ICFC Hôte: Souris Monoclonal BA-17 unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 245-391) antibodyKRT19 Reactivité: Humain WB, IHC, ICC, IP Hôte: Souris Monoclonal D1 unconjugated
anti-Keratin 19 (KRT19) (AA 1-403) antibodyKRT19 Reactivité: Souris WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 127-322) antibodyKRT19 Reactivité: Humain WB, IHC, ICC, IP Hôte: Souris Monoclonal C1 unconjugated
anti-Keratin 19 (KRT19) (AA 241-400) antibodyKRT19 Reactivité: Humain WB, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Keratin 19 (KRT19) (AA 80-400) antibodyKRT19 Reactivité: Humain, Rat WB, IHC, FACS, ELISA Hôte: Souris Monoclonal 2A1G9 unconjugated
anti-Keratin 19 (KRT19) (AA 274-400) antibodyKRT19 Reactivité: Humain WB, IHC, ELISA Hôte: Souris Monoclonal 8H1A8 unconjugated
anti-Keratin 19 (KRT19) antibodyKRT19 Reactivité: Humain, Souris, Rat IHC, FACS, IF, StM Hôte: Souris Monoclonal KRT19-800 unconjugated
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C/-20°C
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Autre désignation
- CK-19/KRT19
-
UniProt
- P08727
Antigène
-
